Studies have found that the gene encoding Lgr5 (leucine-rich-repeat-containing G-protein-coupled receptor 5) is expressed in colon cancer cells and in ovarian and hepatocellular carcinomas.
Analyst Ami Fadia of Needham maintained a Buy rating on Merus (MRUS – Research Report), retaining the price target of $85.00.Pick the best ...